BioLife Solutions, Inc.

NasdaqCM:BLFS

Market Cap

USD 1.05 B

Share Price

USD 21.95

Avg Daily Volume

604,801

Change (1 day)

-3.39%

Change (1 year)

4.67%

Change (YTD)

-15.45%

BioLife Solutions, Inc. EBT Margin for the Trailing 12 Months (TTM) ending September 30, 2024: -26.26%

BioLife Solutions, Inc. EBT Margin is -26.26% for the Trailing 12 Months (TTM) ending September 30, 2024, a -60.19% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.
  • BioLife Solutions, Inc. EBT Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was -65.96%.
  • BioLife Solutions, Inc. EBT Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was -16.67%, a -285.88% change year over year.
  • BioLife Solutions, Inc. EBT Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was 8.97%, a -80.83% change year over year.
Key Data
Date EBT Margin Operating Income Margin Gross Profit Margin EBIT Margin